PCRX vs ENTA
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Nov 12, 2026
PCRX
ENTA
Investment Advisor Scores
ENTA
AI Analyst Insights
Detailed Metrics Comparison
| Metric | PCRX | ENTA | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 9.8912 | 44.0529 | PCRX |
| PEG Ratio | 0.9893 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -1.6% | -21.6% | PCRX |
| Earnings Growth | 483.3% | -66.2% | PCRX |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 45.6/100 | 49.4/100 | ENTA |
| Profit Margin | 5.1% | -96.9% | PCRX |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | BUY | ENTA |
Relative Price Performance (Last 90 Days)
Current Technical Phase
PCRX
MarkupPrice above SMA50, rising 50-day trend (17.9% over 20 days), RSI 82
ENTA
NeutralMixed signals - no dominant trend phase, RSI 51
Fundamentals Snapshot
| Metric | PCRX | ENTA |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 10.5 | -4.9 |
| Trailing P/E | 39.2 | — |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.0% | -0.2% |
| Gross Margin | 0.8% | 1.0% |
| Operating Margin | 0.1% | -1.2% |
| EPS | 0.93 | -2.42 |
| Dividend Yield | — | — |